Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Longo

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
The Journal of Pathology|September 24, 2005
Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cellsSimona Coco, Raffaella Defferrari, Paola Scaruffi, et al.
Journal of Translational Medicine|May 19, 2016
An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastomaDaniela Formicola, Giuseppe Petrosino, Vito Alessandro Lasorsa, et al.
Oncogene|November 26, 2002
Weak linkage at 4p16 to predisposition for human neuroblastomaPatrizia Perri, Luca Longo, Roberto Cusano, et al.
Plos One|November 9, 2013
High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastomaPaolo Romania, Aurora Castellano, Cecilia Surace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesisDanilo Marimpietri, Chiara Brignole, Beatrice Nico, et al.
Molecular Cancer Research : MCR|June 7, 2011
Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumorsFederica Del Grosso, Simona Coco, Paola Scaruffi, et al.
Carcinogenesis|December 11, 2012
Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibilityMario Capasso, Sharon J Diskin, Francesca Totaro, et al.
Journal of Clinical Medicine|July 13, 2019
Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with NivolumabAngela Alama, Simona Coco, Carlo Genova, et al.
International Journal of Molecular Sciences|April 3, 2021
Novel Emerging Molecular Targets in Non-Small Cell Lung CancerSara Elena Rebuzzi, Lodovica Zullo, Giovanni Rossi, et al.
Cancers|May 6, 2020
Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable PatientGiovanni Rossi, Alessandro Russo, Marco Tagliamento, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
The Journal of Pathology|September 24, 2005
Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cellsSimona Coco, Raffaella Defferrari, Paola Scaruffi, et al.
Journal of Translational Medicine|May 19, 2016
An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastomaDaniela Formicola, Giuseppe Petrosino, Vito Alessandro Lasorsa, et al.
Oncogene|November 26, 2002
Weak linkage at 4p16 to predisposition for human neuroblastomaPatrizia Perri, Luca Longo, Roberto Cusano, et al.
Plos One|November 9, 2013
High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastomaPaolo Romania, Aurora Castellano, Cecilia Surace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesisDanilo Marimpietri, Chiara Brignole, Beatrice Nico, et al.
Molecular Cancer Research : MCR|June 7, 2011
Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumorsFederica Del Grosso, Simona Coco, Paola Scaruffi, et al.
Carcinogenesis|December 11, 2012
Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibilityMario Capasso, Sharon J Diskin, Francesca Totaro, et al.
Journal of Clinical Medicine|July 13, 2019
Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with NivolumabAngela Alama, Simona Coco, Carlo Genova, et al.
International Journal of Molecular Sciences|April 3, 2021
Novel Emerging Molecular Targets in Non-Small Cell Lung CancerSara Elena Rebuzzi, Lodovica Zullo, Giovanni Rossi, et al.
Cancers|May 6, 2020
Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable PatientGiovanni Rossi, Alessandro Russo, Marco Tagliamento, et al.
Pageof 6